Safety · 2026-08-27
Case Report: High-Dose Buprenorphine-Naloxone Successfully Manages Severe 7-OH Withdrawal in VA Patient
Source: Primary Care Companion for CNS Disorders
Why it matters
This peer-reviewed case report documents severe opioid-level withdrawal from commercially sold 7-OH products and shows that standard buprenorphine protocols may be inadequate — requiring doses up to 40 mg in the first 24 hours. Clinicians treating kratom and 7-OH patients need to know this.
The big picture
As 7-OH products spread into retail markets, emergency departments and inpatient units are encountering patients with severe opioid withdrawal who may not disclose their use. Unlike fentanyl, 7-OH does not typically show on standard urine drug screens, creating a diagnostic blind spot. This case, published from the Minneapolis VA Health Care System, illustrates exactly how that blind spot plays out in real clinical settings.
Key findings
- A 49-year-old man admitted for depression was found to be using 1,000 mg/day of 7-OH purchased legally at a tobacco shop
- Initial Clinical Opiate Withdrawal Scale (COWS) scores showed worsening withdrawal despite standard 2 mg buprenorphine-naloxone doses
- Patient required 40 mg of buprenorphine-naloxone in the first 24 hours — far above typical induction doses
- Once stabilized at 32 mg daily, COWS scores dropped below 6 within 36 hours
- Patient had not disclosed 7-OH use at admission due to fear the clinical team would be unfamiliar with its effects
What they say
"This case highlights the potent opioid properties and risk of dependence and withdrawal associated with 7-OH. We encourage clinicians to specifically inquire about 'seven-o' when the use of kratom is reported," wrote authors Jacob T. Held, PharmD, BCPP, and Francisco P. Varicat, DO, both of the Minneapolis VA Health Care System.
Bottom line
Patients using high-dose 7-OH products can experience opioid withdrawal as severe as fentanyl users, and standard buprenorphine protocols may need to be significantly scaled up — clinicians should ask about '7-OH' specifically, as patients often don't volunteer it.